Outcome of Board Meeting

Alpa Laboratories Ltd. 3312, Pigdamber A.B. Road - 453 446 Distt. Indore - (M.P.) India Phone No. : +91 731-429 4567 Fax No. : +91 730-429 4444 Email : mktgdom@alpalabs.in CIN : L85195MP1988PLC004446 Date: - 13" August, 2026 Listing Department, Listing Department, National Stock Exchange of India Limited. Bombay Stock Exchange Limited. ‘Exchange Plaza’, C-1, Block G, Rotunda Building, P J Towers, Bandra - Kurla Complex, Dalal Street, Fort, Bandra (E), Mumbai - 400 051 Mumbai - 400 001 Scrip Code: ALPA Secrip Code: 532878 Subject: Outcome of Board Meeting under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/ Madam, This is with reference to our letter dated 04" August, 2026 in relation to intimation of Board Meeting; this is to inform you that the Board of Directors of the Company at its meeting held today at 3:00 P.M at Registered office of the Company situated at 33/2, A.B. Road Pigdamber Rao, Indore MP 453446 IN. The board inter-alia has approved the following matter: 1. Approval of the Un-Audited Standalone & Consolidated Financial Results of the Company for the Quarter ended on 30" June, 2026 with Limited Review Report from the Statutory Auditor of the Company. 2. Approval of the notice of 38th Annual General Meeting of the Company. This is for the information and record of the exchange and members thereof. The Meeting commenced at 3:00 PM and concluded at 8:00 PM. You are requested to take the same on records. Thanking you, Yours faithfully, FOR ALPA LAl RIES LIMITED 2822 PARESH CHAWLA MANAGING DIRECTOR Alpa Laboratories Ltd. 33/2, AB. Road, Pigdamber-453448, Distt. Indore (M.P.) India Phone No.: +91-731-429 4567 Fax No.: +91-731-429 4444, E-mail: cs@alpalabs.in CIN-L85195MP1988PLC004446 (T in lacs except EPS)] [Financial Results for Quarter ended 30th June 2026 1. Statement of Profit and Loss - Standalone Standalone Results Particulars Quarter Ended Year Ended ‘ Jun-26 Mar-26 Jun-25 Mar-26 Unaudited Audited Unaudited Audited 1. Income a) Revenue from operations 2,393.05] 3,139.56) 1,911.07) 10,580.96 b) Other Income 582.93 (18.38) 1,195.78] 1,572.06 Total income from operations 2,975.98] 3,121.18 3,106.85, 12,153.02 2. Expenses a) Cost of materials consumed 2,153.33 1,659.79) 1,194.34 6,325.37) b) Purchases of stock-in-trade 7.72) 13.18] E 16.41 ©) Changes in inventories of finished products,work in progress and stock in trade (343.27) (64.93) (95.16) 294.08} d) Employee benefit expenses 39289 503.23] 342.53 1,579.60 ¢) Finance costs 11.36) 16.21 5.26) 29.22 ) Depreciation and amortization expense 72.04 22.05 55.33 209.18} g) Other expenses Manufacturing & Operating 258.11 253.88 169.48 794.36) Others 319.96) 41333 257.48 1,240.75 Total expenses 2,872.14) 2,816.74) 1,929.26 10,488.97] 3. Profit /(Loss) before exceptional items and tax (1-2) 103.84] 304.44] 1,177.59) 1,664.05} 4. Exceptional Items | | E 3 5. Profit/ Loss(-) before tax (3+/-4) 103.84 304.44] 1,177.59 1,664.05 6. Tax (Expenses)/ Benefit Current tax - (300.00) - (300.00) Deffered Tax - 115.67) - 115.67) Tax Related to Earlier Years - 15.59) - 15.59) 7. Profit/ Loss(-) for the period (5-/+6) 103.84] 135.70) 1,177.59 T,495.31 8. Other Comprehensive Income (i) (a) Items that will not be reclassified to profit or loss 5.93 (88.40) - (88.40) (b) Tax expense/(benefit) on items that will not be reclassified to profit or loss . g ] ] (ii) (a) Items that will be reclassified to profit & loss d d | ] (b) Tax expense/(benefit) on items that will be reclassified to profit or loss Total Other comprehensive (loss)/ income (net of tax) 593 (88.40)| E (88.40)| 9. Total comprehensive income for the period 109.78) 47.30) 1,177.59) 1,406.91 10. Paid-up equity share capital (Face Value Rs. 10 Each) 2,104.06] 2,104.06) 2,104.06) 2,104.06 11 Other equity ( excluding revalution reserve) 17,990.33) 12.Debenture Redumption Reserve 13. Basic and Diluted Earnings per share after extraordinery items e 0.52) 0.22) 5.60) 6.69) .@&\fld. s.% 5 ) & R/ /& Notes - 1. The above Consolidated Unaudited Financial Results of Alpa Laboratories Limited has been reviewed by the Audit Committee and subsequently approved by the Board of Directors. The Statutory Auditor of the Company have carried out a Limited Review on Consolidated Financial Results and have expressed an unmodified Review Conclusion. 2. This statement has been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015 (Ind AS) prescibed under Section 133 of the Companies Act, read with rule 3 of the Companies ( Indian accounting Standards) Rules, 2015 and Companies (Indian Accounting Standards ) Accounting Rules, 2016 3. The Company is operating in the single segment of Drugs & Chemicals. 4. The Figures of Previous Year/ Periods may have been regrouped/reclassified/restated wherever necessary. 5. Other Income for the quarter includes unrealized profit occurred on account of increase in fair market value of the investments. 6. The Statement includes the financial results for the quarter ended 30th June, 2026 being the balancing figure between audited figures in respect of the full financial year ended March 31, 2026 and the published unaudited year to date figure up to the first quarter of the financial year ended March 31, 2027 which were subject to limited review by the statutory auditors. Place: Indore i By order of the board Date: August 13, 2026 For Alpa Labg#atories Limited PARESH CHAWLA MANAGING DIRECTOR Alpa Laboratories Ltd. 33/2, A.B. Road, Pigdamber-453446, Distt. Indore (M.P.) India Phone No.: +91-731-429 4567 Fax No.: +91-731-429 4444, E-mail: cs.alpalabs@gmail.com CIN-L85195MP1988PLC004446 [Financial Results for Quarter ended 30th June 2026 (Zin lacs except EPS)| I1. Statement of Profit and Loss - Consolidated Consolidated Results 3 Quarter Ended Year Ended g R Jun26 Mar-26 Jun-25 Mar-26 5 Unaudited Audited Unaudited Audited 1. Income a) Revenue from operations 2,393.05] 3,139.56] 1911.07) 10,580.96 b) Other Income 576.80 (15.86) 1,194.47) 1,575.68] Total income from operations 2,969.35] 3,123.70) 3,105.54] 12,156.64] 2. Expenses a) Cost of materials consumed 2,153.33] 1,659.79) 1,194.34] 6,325.37) b) Purchases of stock-in-trade 7.72) 13.18] - 16.41 ©) Changes in inventories of finished products,work in progress and stock in trade L(343.27) (64.93) (95.16) 294.08} d) Employee benefit expenses 392.89) 50431 342.53) 1,580.68] ¢) Finance costs 11.03) 14.87 4.75) 25.80 1) Depreciation and amortization expense e 22,05 55.33) 209.18} g) Other expenses Manufacturing& Operating 258.11 253.88] 169.48] 794.36) Others 319.96 413.55] 257.48 1,241.04) Total expenses 2,871.81 2,816.70) 1,028.76, 10,486.92] 3. Profit /(Loss) before exceptional items and tax (1-2) 98.04] 307.00) 1,176.78 1,669.72 4. Exceptional Items 3 3 8 - 5. Profit/ Loss(-) before tax (3+/-4) 98.04] 307.00] 1,176.78 1,669.72 6. Tax (Expenses)/ Benefit E (300.00)| g (300.00)| (Current tax Deffered Tax E 115.67) g 115.67 Tax Related to Earlier Years 4 15.59) | 15.59) 7. Profit/ Loss(-) for the period (5-+6) 98.04 138.26) 1,176.79 T,500.98] 8. Other Comprehensive Income (i) (a) Items that will not be reclassified to profit or loss 5.93 (88.39) - (88.39) (b) Tax expense/(benefit) on items that will not be reclassified to profit or loss - g - (ii) (a) Items that will be reclassified to profit & loss - - 9 (b) Tax expense/(benefit) on items that will be reclassified to profit or loss Total Other comprehensive (loss)/ income (net of tax) 5.93) (88.39) | (88.39) 9. Total comprehensive income for the period 103.97) 49.87] 1,176.78 1,412.59] 10. Paid-up equity share capital (Face Value Rs. 10 Each) 2,104.06 2,104.06| 2,104.06 2,104.06} 11. Other equity ( excluding revalution reserve) 16,524.03) 12.Debenture Redumption Reserve 13. Basic and Diluted Earnings per share after extraordinery items o] ] e a (not annualized) Notes - 1. The above Standalone Unaudited Financial Results of Alp [Showing first 8,000 characters — download PDF for full document]